Sandra Heskamp

4.1k citations

105 papers · 2.7k · 1 hit paper · h-index 31

Impact in

Radiology, Nuclear Medicine and Imaging top 0.5%
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
Oncology top 2%
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Radiology, Nuclear Medicine and Imaging 56
- Radiopharmaceutical Chemistry and Applications 44
- Medical Imaging Techniques and Applications 13
- Monoclonal and Polyclonal Antibodies Research 10
Oncology 35
- Cancer Immunotherapy and Biomarkers 16
- Peptidase Inhibition and Analysis 9

Co-authors: Otto C. Boerman (40 shared papers)Janneke D.M. Molkenboer‐Kuenen (25 shared papers)Wim J.G. Oyen (20 shared papers)Mark Rijpkema (16 shared papers)Martin Gotthardt (16 shared papers)Winette T.A. van der Graaf (15 shared papers)Johan Bussink (21 shared papers)Gerben M. Franssen (20 shared papers)
Journals: Theranostics (9 papers)European Journal of Nuclear Medicine and Molecular Imaging (8 papers)Molecular Pharmaceutics (7 papers)Journal of Nuclear Medicine (7 papers)Clinical Cancer Research (5 papers)
Partner nations: Netherlands Germany United States

In The Last Decade

Sandra Heskamp

101 papers receiving 2.7k citations

Sandra Heskamp's Hit Papers

align trajectories log scale

Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies 2023 · 113 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 European Journal of Nuclear Medicine and Molecular Imaging

Peers

Countries citing papers authored by Sandra Heskamp

Since Specialization

Citations

This map shows the geographic impact of Sandra Heskamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Heskamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Heskamp more than expected).

Fields of papers citing papers by Sandra Heskamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Heskamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Heskamp. The network helps show where Sandra Heskamp may publish in the future.

Co-authors

The 25 scholars most cited alongside Sandra Heskamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandra Heskamp Line = papers co-authored together Sandra Heskamp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti–PD-L1 Antibodies Cancer Research ·Sandra Heskamp, Willemijn Hobo, Janneke D.M. Molkenboer‐Kuenen, Daniel Olive, Wim J.G. Oyen, Harry Dolstra, Otto C. Boerman	2015	193
2	PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status Theranostics ·Susanne Lütje, Sandra Heskamp, Alexander S. Cornelissen, Thorsten D. Poeppel, Sebastiaan A. M. W. van den Broek, Sandra Rosenbaum‐Krumme, Andreas Bockisch, Martin Gotthardt, Mark Rijpkema, Otto C. Boerman	2015	177
3	⁸⁹Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art ⁸⁹Zr Radiochemistry Bioconjugate Chemistry ·Sandra Heskamp, René Raavé, Otto C. Boerman, Mark Rijpkema, Victor Gonçalves, Franck Denat	2017	154
4	Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies European Journal of Nuclear Medicine and Molecular Imaging ·Bastiaan M. Privé, Mohamed A. Boussihmad, Bart Timmermans, Willemijn A. van Gemert, Steffie M. B. Peters, Yvonne H. W. Derks, Sanne A. M. van Lith, Niven Mehra, James Nagarajah, Sandra Heskamp, Harm Westdorp Hit paper breakdown →	2023	113
5	Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent Theranostics ·Kristell L.S. Chatalic, Sandra Heskamp, Mark Konijnenberg, Janneke D.M. Molkenboer‐Kuenen, Gerben M. Franssen, Marian C. Clahsen‐van Groningen, Margret Schottelius, Hans‐Jürgen Wester, Wytske M. van Weerden, Otto C. Boerman, Marion de Jong	2016	104
6	PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports European Journal of Nuclear Medicine and Molecular Imaging ·Maike J.M. Uijen, Yvonne H. W. Derks, Robin Merkx, Melline G.M. Schilham, Jens Ulrik Roosen, Bastiaan M. Privé, Sanne A. M. van Lith, Carla M.L. van Herpen, Martin Gotthardt, Sandra Heskamp, Willemijn A. M. van Gemert, James Nagarajah	2021	100
7	Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy Clinical Cancer Research ·Daan F. Boreel, Paul N. Span, Sandra Heskamp, Gosse J. Adema, Johan Bussink	2021	80
8	Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma European Journal of Nuclear Medicine and Molecular Imaging ·Sarah R. Verhoeff, Suzanne C. van Es, Eline Boon, Erik van Helden, Lindsay Angus, Sjoerd G. Elias, Sjoukje F. Oosting, Erik H.J.G. Aarntzen, Adrienne H. Brouwers, Thomas C. Kwee, Sandra Heskamp, Otto S. Hoekstra, Henk M.W. Verheul, Astrid A.M. van der Veldt, Elisabeth G.E. de Vries, Otto C. Boerman, Winette T.A. van der Graaf, Wim J.G. Oyen, Carla M.L. van Herpen	2019	74
9	ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model Journal of Nuclear Medicine ·Sandra Heskamp, Hanneke W.M. van Laarhoven, Janneke D.M. Molkenboer‐Kuenen, Gerben M. Franssen, Yvonne M.H. Versleijen‐Jonkers, Wim J.G. Oyen, Winette T.A. van der Graaf, Otto C. Boerman	2010	73
10	Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET European Journal of Nuclear Medicine and Molecular Imaging ·René Raavé, Gerwin W. Sandker, Pierre Adumeau, Christian Jacobsen, Floriane Mangin, Michel Meyer, Mathieu Moreau, Claire Bernhard, Laurène Da Costa, Adrien S. DuBois, Victor Gonçalves, Magnus Gustafsson, Mark Rijpkema, Otto C. Boerman, Jean‐Claude Chambron, Sandra Heskamp, Franck Denat	2019	73
11	Imaging of T-cells and their responses during anti-cancer immunotherapy Theranostics ·Massis Krekorian, Gilbert O. Fruhwirth, Mangala Srinivas, Carl G. Figdor, Sandra Heskamp, Timothy H. Witney, Erik H.J.G. Aarntzen	2019	72
12	PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery Theranostics ·Yvonne H. W. Derks, Dennis W. P. M. Löwik, J.P. Michiel Sedelaar, Martin Gotthardt, Otto C. Boerman, Mark Rijpkema, Susanne Lütje, Sandra Heskamp	2019	65
13	The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier Scientific Reports ·Robin M. de Kruijff, René Raavé, Annemarie Kip, Janneke D.M. Molkenboer‐Kuenen, Alfred Morgenstern, Frank Bruchertseifer, Sandra Heskamp, Antonia G. Denkova	2019	64
14	Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with ¹⁸F-Labeled Affibody Molecule Z_HER2_:2395 in a Mouse Model for Ovarian Cancer Journal of Nuclear Medicine ·Sandra Heskamp, Peter Laverman, Daniel Rosik, Fréderic Boschetti, Winette T.A. van der Graaf, Wim J.G. Oyen, Hanneke W.M. van Laarhoven, Vladimir Tolmachev, Otto C. Boerman	2011	60
15	²¹³ Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts Cancer Biotherapy and Radiopharmaceuticals ·Julie Nonnekens, Kristell L.S. Chatalic, Janneke D.M. Molkenboer‐Kuenen, Cecile Beerens, Frank Bruchertseifer, Aliyah Morgenstern, Joke Veldhoven-Zweistra, Margret Schottelius, Hans‐Jürgen Wester, Dik C. van Gent, Wytske M. van Weerden, Otto C. Boerman, Marion de Jong, Sandra Heskamp	2017	53
16	A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint OncoImmunology ·Iris Koopmans, Djoke Hendriks, Douwe F. Samplonius, Robert J. van Ginkel, Sandra Heskamp, Peter J. Wierstra, Edwin Bremer, Wijnand Helfrich	2018	53
17	Theranostic applications of antibodies in oncology Molecular Oncology ·Emmy D.G. Fleuren, Yvonne M.H. Versleijen‐Jonkers, Sandra Heskamp, Carla M.L. van Herpen, Wim J.G. Oyen, Winette T.A. van der Graaf, Otto C. Boerman	2014	49
18	Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti‐insulin‐like growth factor 1 receptor antibodies International Journal of Cancer ·Sandra Heskamp, Otto C. Boerman, Janneke D.M. Molkenboer‐Kuenen, Wim J.G. Oyen, Winette T.A. van der Graaf, Hanneke W.M. van Laarhoven	2013	44
19	Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity Scientific Reports ·Robin A. Nadar, Kambiz Farbod, Karlijn Codée-van der Schilden, Lukas Schlatt, Barbara Crone, Nandini Asokan, Alessandra Curci, Michael Brand, Martin Bornhaeuser, Michele Iafisco, Nicola Margiotta, Uwe Kärst, Sandra Heskamp, Otto C. Boerman, Jeroen J.J.P. van den Beucken, Sander C.G. Leeuwenburgh	2020	44
20	Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment Clinical Cancer Research ·Simone C. Kleinendorst, Egbert Oosterwijk, Johan Bussink, Harm Westdorp, Mark Konijnenberg, Sandra Heskamp	2022	43

About Sandra Heskamp

Sandra Heskamp is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 105 papers that have together received 2.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (44 papers), Cancer, Hypoxia, and Metabolism (18 papers), Prostate Cancer Treatment and Research (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), Medical Imaging Techniques and Applications (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Peptidase Inhibition and Analysis (9 papers) and Nanoplatforms for cancer theranostics (9 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.3k citations), Oncology (1.0k citations), Pulmonary and Respiratory Medicine (815 citations), Cancer Research (265 citations) and Immunology (237 citations). Sandra Heskamp has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Otto C. Boerman, Janneke D.M. Molkenboer‐Kuenen, Wim J.G. Oyen, Mark Rijpkema, Martin Gotthardt, Winette T.A. van der Graaf, Johan Bussink, Gerben M. Franssen, Susanne Lütje and Erik H.J.G. Aarntzen. Their work appears in journals such as Theranostics, European Journal of Nuclear Medicine and Molecular Imaging, Molecular Pharmaceutics, Journal of Nuclear Medicine and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Sandra Heskamp

Impact in

Papers in i

In The Last Decade

Sandra Heskamp

Sandra Heskamp's Hit Papers

Peers

Countries citing papers authored by Sandra Heskamp

Fields of papers citing papers by Sandra Heskamp

All Works

About Sandra Heskamp

Explore authors with similar magnitude of impact

Papers in